Association between non-adherence behaviors, patients? experience with healthcare and beliefs in medications: a survey of patients with different chronic conditions
Por:
Cea-Calvo L, Marín-Jiménez I, de Toro J, Fuster-RuizdeApodaca MJ, Fernández G, Sánchez-Vega N and Orozco D
Publicada:
1 feb 2020
Ahead of Print:
1 oct 2019
Categoría:
Medicine (miscellaneous)
Resumen:
Objective: The objective of the current work was to assess the frequency of non-adherence behaviors and potential association with patients? experience with healthcare and beliefs in medicines self-reported by patients with four different chronic conditions. Methods: Patients responded anonymously to a survey comprising five non-adherence behaviors (based on physician and patient input), an assessment of patients? experience with healthcare using the validated Instrument to Evaluate the EXperience of PAtients with Chronic diseases (IEXPAC), and a validated Spanish version of the Beliefs about Medicines Questionnaire (BMQ). Associations of non-adherence behavior were analyzed using logistic regression models. Results: Of 1530 respondents, 53.1% reported ?1 non-adherence behavior. Non-adherence rates were 59.8% in diabetes mellitus (DM), 56.0% in rheumatic disease, 55.6% in inflammatory bowel disease, and 42.8% in human immunodeficiency virus (HIV) infection patients (p < .001). IEXPAC and BMQ scores were higher in adherent vs. non-adherent patients. In multivariate analysis, non-adherence behavior was strongly associated with lower overall BMQ, lower BMQ Necessity scores and higher BMQ Concerns scores (p < .001 for all), and with a lower IEXPAC self-management score (p = .007), but not with the overall IEXPAC score. Non-adherence was more frequent in DM patients compared with HIV infection patients (p < .001). Conclusions: Patients? beliefs in medicines-a lower perception for the necessity of medication, and higher concerns in taking medication-and low patient self-management experience score were associated with non-adherence behavior. These are modifiable aspects that need to be addressed to increase medication adherence in chronic disease.
Filiaciones:
Cea-Calvo L:
Medical Affairs Department, Merck Sharp & Dohme Spain, Madrid, Spain
Marín-Jiménez I:
IBD Unit, Gastroenterology Department, Clinical Research Institute Gregorio Marañón (IiSGM), Gregorio Marañón University Hospital, Madrid, Spain
de Toro J:
Rheumatology Department, A Coruña University Hospital, A Coruña, Spain
Fuster-RuizdeApodaca MJ:
SEISIDA (Spanish AIDS Multidisciplinary Society), Madrid, Spain
Fernández G:
Medical Affairs Department, Merck Sharp & Dohme Spain, Madrid, Spain
Sánchez-Vega N:
Medical Affairs Department, Merck Sharp & Dohme Spain, Madrid, Spain
Orozco D:
Clinical Medicine Department, Miguel Hernandez University, San Juan de Alicante, Spain
hybrid, Green Submitted
|